Hyftor (sirolimus topical gel) — United Healthcare
facial angiofibroma associated with tuberous sclerosis
Initial criteria
- Diagnosis of tuberous sclerosis
- AND Patient has facial angiofibroma associated with tuberous sclerosis
Reauthorization criteria
- Documentation of positive clinical response to therapy (e.g., improvement in skin lesions)
Approval duration
12 months